Akinyemi Akinwumiju

Esmethadone in Major Depressive Disorder: Pharmacology and Clinical Evidence

Olaniyi David Ogundeji, Nkechinyere M Harry, Akinyemi Akinwumiju, Obianuju Nwauwa, Gibson Anugwom & Samuel Nwaobi · Journal of Advances in Medicine and Medical Research · 2025

Major Depressive Disorder (MDD) affects approximately 280 million people globally, with current treatments showing significant limitations, including delayed onset of action, low remission rates, and troublesome side effects. Esmethadone (REL-1017, d-methadone) has emerged as a p...

Open access Research Article 10.9734/jammr/2025/v37i85919

Transcranial Magnetic Stimulation for the Rehabilitation of Broca's Aphasia: A Review of Current Protocols and Clinical Outcomes

Gibson Anugwom, Nkechinyere Mary Harry, Afolarin Ishola, Obianuju Nwauwa, Akinyemi Akinwumiju & Olaniyi David Ogundeji · Journal of Advances in Medicine and Medical Research · 2025

Stroke constitutes a leading global cause of long-term disability, leaving a significant percentage of survivors with persistent neurological deficits that compromise their independence and quality of life. Post-stroke Broca's aphasia represents a significant source of chronic di...

Open access Research Article 10.9734/jammr/2025/v37i75889